{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:43:27Z","timestamp":1649108607042},"reference-count":34,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2018.1767","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T11:37:48Z","timestamp":1542368268000},"source":"Crossref","is-referenced-by-count":0,"title":["Early administration of systemic chemotherapy should be\ufffdconsidered for scirrhous gastric cancer: A case report"],"prefix":"10.3892","author":[{"given":"Yu","family":"Aoki","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hamamoto","sequence":"additional","affiliation":[{"name":"Keio Cancer Center, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Ugamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Togasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenro","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Kasuga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Sukawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Takaishi","sequence":"additional","affiliation":[{"name":"Keio Cancer Center, Keio University School of Medicine, Tokyo 160\u20118582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"key20200713202220_b1-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20200713202220_b2-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","year":"2011","journal-title":"Gastric Cancer"},{"key":"key20200713202220_b3-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"S1668","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1668::AID-CNCR37>3.0.CO;2-W","article-title":"Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as \u2018soil\u2019 for peritoneal dissemination","volume":"77","author":"Yashiro","year":"1996","journal-title":"Cancer"},{"key":"key20200713202220_b4-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jso.2930580208","article-title":"Clinicopathologic study of patients with Borrmann type IV gastric carcinoma","volume":"58","author":"Kitamura","year":"1995","journal-title":"J Surg Oncol"},{"key":"key20200713202220_b5-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/BF02806351","article-title":"Retroperitoneal fibrosis associated with scirrhous gastric cancer","volume":"28","author":"Dohmen","year":"1993","journal-title":"Gastroenterol Jpn"},{"key":"key20200713202220_b6-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4251\/wjgo.v5.i3.68","article-title":"Gastroesophageal cancer and retroperitoneal fibrosis: Two case reports and review of the literature","volume":"5","author":"Peixoto","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"key20200713202220_b7-mco-0-0-1767","first-page":"988","article-title":"Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint","volume":"34","author":"Sasaki","year":"2007","journal-title":"Gan To Kagaku Ryoho"},{"key":"key20200713202220_b8-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1359-6349(09)71231-5","article-title":"5 FU\/l LV(RPMI) versus S 1 as first line therapy in patients with advanced gastric cancer: A randomized phase III non inferiority trial (ISO 5FU10 study group trial)","volume":"7","author":"Sawaki","year":"2009","journal-title":"Eur J Cancer, Suppl"},{"key":"key20200713202220_b9-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key20200713202220_b10-mco-0-0-1767","journal-title":"Common Terminology Criteria for Adverse Events (CTCAE)"},{"key":"key20200713202220_b11-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/mco.2015.510","article-title":"Complications in advanced or recurrent gastric cancer patients with peritoneal metastasis during and after palliative systemic chemotherapy","volume":"3","author":"Hamamoto","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"key20200713202220_b12-mco-0-0-1767","first-page":"250","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"81","author":"Koep","year":"1977","journal-title":"Surgery"},{"key":"key20200713202220_b13-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"key":"key20200713202220_b14-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/bjs.1800540602","article-title":"Malignant retroperitoneal fibrosis","volume":"54","author":"Webb","year":"1967","journal-title":"Br J Surg"},{"key":"key20200713202220_b15-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/bjc.1973.171","article-title":"Retroperitoneal fibrosis associated with malignant disease","volume":"28","author":"Thomas","year":"1973","journal-title":"Br J Cancer"},{"key":"key20200713202220_b16-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2214\/AJR.07.3629","article-title":"Retroperitoneal fibrosis: A review of clinical features and imaging findings","volume":"191","author":"Cronin","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"key20200713202220_b17-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0090-4295(77)90198-4","article-title":"Retroperitoneal fibrosis secondary to metastatic neoplasm","volume":"9","author":"Usher","year":"1977","journal-title":"Urology"},{"key":"key20200713202220_b18-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.2169\/internalmedicine.51.7660","article-title":"Retroperitoneal fibrosis in a patient with gastric cancer manifested by lower extremity edema and hydrocele","volume":"51","author":"Yokoyama","year":"2012","journal-title":"Intern Med"},{"key":"key20200713202220_b19-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2478\/v10019-010-0015-y","article-title":"Ureteral metastasis as the first and sole manifestation of gastric cancer dissemination","volume":"44","author":"Bisof","year":"2010","journal-title":"Radiol Oncol"},{"key":"key20200713202220_b20-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/PL00011693","article-title":"Gastric cancer recognized by metastasis to the ureter","volume":"3","author":"Shimoyama","year":"2000","journal-title":"Gastric Cancer"},{"key":"key20200713202220_b21-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10120-001-8012-x","article-title":"Sequential methotrexate and 5 fluorouracil therapy for gastric cancer patients with peritoneal dissemination: A retrospective study","volume":"4","author":"Tahara","year":"2001","journal-title":"Gastric Cancer"},{"key":"key20200713202220_b22-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/1097-0142(197803)41:3<941::AID-CNCR2820410323>3.0.CO;2-M","article-title":"Adenocarcinoma of the stomach: Review of 1,497 cases","volume":"41","author":"Dupont","year":"1978","journal-title":"Cancer"},{"key":"key20200713202220_b23-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/jjco\/hyt114","article-title":"Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group: Randomized Phase III study of 5 fluorouracil continuous infusion vs. sequential methotrexate and 5 fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)","volume":"43","author":"Shirao","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key20200713202220_b24-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s10120-015-0542-8","article-title":"Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group: Randomized phase II study of second line chemotherapy with the best available 5 fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5 fluorouracil containing regimens (JCOG0407)","volume":"19","author":"Nishina","year":"2016","journal-title":"Gastric Cancer"},{"key":"key20200713202220_b25-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10147-010-0135-9","article-title":"Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: A retrospective study","volume":"16","author":"Iwasa","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"key20200713202220_b26-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1634\/theoncologist.12-9-1070","article-title":"Commentary: Oncologic drugs in patients with organ dysfunction: a summary","volume":"12","author":"Superfin","year":"2007","journal-title":"Oncologist"},{"key":"key20200713202220_b27-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S1470-2045(08)70307-3","article-title":"Part II: Liver function in oncology: Towards safer chemotherapy use","volume":"9","author":"Field","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20200713202220_b28-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/annonc\/mdp598","article-title":"Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients","volume":"21","author":"Janus","year":"2010","journal-title":"Ann Oncol"},{"key":"key20200713202220_b29-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","article-title":"Clinical significance of serum tumor markers for gastric cancer: A systematic review of literature by the Task Force of the Japanese Gastric Cancer Association","volume":"17","author":"Shimada","year":"2014","journal-title":"Gastric Cancer"},{"key":"key20200713202220_b30-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","article-title":"FDG PET imaging of locally advanced gastric carcinomas: Correlation with endoscopic and histopathological findings","volume":"30","author":"Stahl","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key20200713202220_b31-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00261-016-0652-8","article-title":"Computed tomography features of gastrointestinal linitis plastica: Spectrum of findings in early and delayed phase imaging","volume":"41","author":"Burgain","year":"2016","journal-title":"Abdom Radiol (NY)"},{"key":"key20200713202220_b32-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12957-017-1187-3","article-title":"The significance of a nineteenth century definition in the era of genomics: Linitis plastica","volume":"15","author":"Agnes","year":"2017","journal-title":"World J Surg Oncol"},{"key":"key20200713202220_b33-mco-0-0-1767","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","article-title":"Japanese gastric cancer association. Japanese gastric cancer treatment guidelines 2014 (ver.4)","volume":"20","year":"2017","journal-title":"Gastric Cancer"},{"key":"key20200713202220_b34-mco-0-0-1767","journal-title":"NCCN Clinical Practice Guideline in Oncology (NCCN Guidelines\u00ae)"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:22:26Z","timestamp":1594668146000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2018.1767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3892\/mco.2018.1767","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]}}}